Healthcare & Life Sciences
NovoGI
Germanynovogi.com
NovoGI is a Healthcare & Life Sciences startup based in Germany, most recent round Series B, 1 tracked investor.
Defunctseries-b
series-b
Stage
1
Investors
About NovoGI
NovoGI is a company headquartered in Germany. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
NovoGI is developing a novel, non-invasive diagnostic platform for gastrointestinal diseases. Their technology uses advanced biomarker analysis for early detection of conditions like inflammatory bowel disease (IBD) and colorectal cancer.
Explore NovoGI's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.